controlled substances; approval; use; research

SB 1542 requires Arizona employers to cover workers' compensation for firefighters and certified peace officers diagnosed with PTSD who need Midomafetamine treatment, provided an independent medical exam approves it as a necessary treatment. The bill mandates annual cost reports to the legislature starting in 2029 and specifies that Midomafetamine must meet state controlled substance regulations. It also allocates $10 million for clinical research and training on Midomafetamine treatment for PTSD, specifically targeting first responders and veterans. The coverage and funding provisions are conditional on the FDA approving Midomafetamine for PTSD treatment by 2029.